AI assistant
Sending…
Cardiff Oncology, Inc. — Director's Dealing 2021
Jun 14, 2021
33967_dirs_2021-06-14_fb185e1d-fd42-4820-a9b6-3b3b2bbd66b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cardiff Oncology, Inc. (CRDF)
CIK: 0001213037
Period of Report: 2021-06-10
Reporting Person: TANNENBAUM RENEE P (Director)
More from Cardiff Oncology, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Feb 25
Regulatory Filings
2026
Feb 24
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 9